185 related articles for article (PubMed ID: 20387650)
1. [Influence of liposomal glucosaminyl-muramyl dipeptide on superoxide and nitric oxide production by murine macrophages].
Parshykov OV; Stefanov OV
Ukr Biokhim Zh (1999); 2009; 81(5):74-82. PubMed ID: 20387650
[TBL] [Abstract][Full Text] [Related]
2. Glucosaminylmuramyl dipeptide-induced changes in murine macrophage metabolism.
Balitsky KP; Umansky VY; Tarakhovsky AM; Andronova TM; Ivanov VT
Int J Immunopharmacol; 1989; 11(5):429-34. PubMed ID: 2553620
[TBL] [Abstract][Full Text] [Related]
3. [The effect of muramyl dipeptide analog, GMPD, incorporated into liposomes of various composition on the functional activity of macrophages].
Stefanov AV; Bondar' OP; Umanskiĭ VIu; Lishko VK; Baletskiĭ KP
Ukr Biokhim Zh (1978); 1989; 61(6):63-9. PubMed ID: 2561033
[TBL] [Abstract][Full Text] [Related]
4. The effect of glucosaminylmuramyl dipeptide injection to mice on the course of tuberculous infection and in vitro superoxide anion production.
Venkataprasad N; Ledger P; Ivanyi J
Int Arch Allergy Immunol; 1997 Sep; 114(1):23-9. PubMed ID: 9303327
[TBL] [Abstract][Full Text] [Related]
5. Induction of nitric oxide production and tumoricidal properties in murine macrophages by a new synthetic lipopeptide JBT3002 encapsulated in liposomes.
Eue I; Kumar R; Dong Z; Killion JJ; Fidler IJ
J Immunother; 1998 Sep; 21(5):340-51. PubMed ID: 9789196
[TBL] [Abstract][Full Text] [Related]
6. [Changes in purine metabolism in the macrophages of mice exposed to a new synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Tarakhovskiĭ AM; Andronova TM
Biull Eksp Biol Med; 1985 Jun; 99(6):685-7. PubMed ID: 2990603
[TBL] [Abstract][Full Text] [Related]
7. Muramylpeptides augment expression of Ia-antigens on mouse macrophages.
Nesmeyanov VA; Khaidukov SV; Komaleva RL; Andronova TM; Ivanov VT
Biomed Sci; 1990 Feb; 1(2):151-4. PubMed ID: 2102779
[TBL] [Abstract][Full Text] [Related]
8. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
9. [Effect of GMDP encapsulated into liposomes on metastatic spread of Lewis lung carcinoma].
Umanskiĭ VIu; Stefanov AV; Bondar' OP; Braginskiĭ SA; Balitskiĭ KP
Eksp Onkol; 1988; 10(5):40-3. PubMed ID: 2850149
[TBL] [Abstract][Full Text] [Related]
10. [Immunostimulating effects of muramyl dipeptide, glucosaminyl muramyl dipeptide and their synthetic derivatives in vitro].
Rakhmilevich AL; Rakhimova MS; Andronova TM; Bovin NV
Antibiot Khimioter; 1989 Aug; 34(8):586-9. PubMed ID: 2589897
[TBL] [Abstract][Full Text] [Related]
11. [Activation of cellular immunity in mice under normal conditions and in tumor growth during treatment with glucosaminyl muramyl dipeptide].
Pimenov AA; Rakhmilevich AL; Deev VV; Kirillova IV; Migdal TL; Andronova TM; Fuks BB
Vopr Med Khim; 1990; 36(1):58-60. PubMed ID: 2343578
[TBL] [Abstract][Full Text] [Related]
12. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
Hornung RL; Longo DL; Gowda VL; Kwak LW
Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
[TBL] [Abstract][Full Text] [Related]
13. In vivo modulation of macrophage tumoricidal activity by oral administration of the liposome-encapsulated macrophage activator CGP 19835A.
Tanguay S; Bucana CD; Wilson MR; Fidler IJ; von Eschenbach AC; Killion JJ
Cancer Res; 1994 Nov; 54(22):5882-8. PubMed ID: 7954418
[TBL] [Abstract][Full Text] [Related]
14. [Immunostimulating properties of synthetic derivatives of muramyl dipeptide and glucosaminyl muramyl dipeptide in vitro].
Rakhmilevich AL; Migdal TL; Rakhimova MS; Shneĭderova MA; Chirva VIa; Zemliakov AE
Antibiot Khimioter; 1989 Nov; 34(11):836-9. PubMed ID: 2633699
[TBL] [Abstract][Full Text] [Related]
15. [The action of pertussis vaccines and GMDP on the change in the enzymatic activity of macrophages from peritoneal exudate].
Ermolova EV; Britsina MV; Ozeretskovskaia MN; Shepeleva IB; Zakharova NS
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):56-9. PubMed ID: 10876852
[TBL] [Abstract][Full Text] [Related]
16. Evidence of differential mycobacterial growth and modulation of mycobactericidal property by glucoaminylmuramyl dipeptide in murine macrophages.
Venkataprasad N
Ann N Y Acad Sci; 1997 Dec; 832():117-29. PubMed ID: 9704041
[TBL] [Abstract][Full Text] [Related]
17. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs.
Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P
J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784
[TBL] [Abstract][Full Text] [Related]
18. N-acetylglucosamine-containing muramyl peptides directly affect macrophages.
Khaidukov SV; Komaleva RL; Nesmeyanov VA
Int J Immunopharmacol; 1995 Nov; 17(11):903-11. PubMed ID: 8788120
[TBL] [Abstract][Full Text] [Related]
19. Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion.
Pabst MJ; Cummings NP; Shiba T; Kusumoto S; Kotani S
Infect Immun; 1980 Aug; 29(2):617-22. PubMed ID: 6260655
[TBL] [Abstract][Full Text] [Related]
20. GMDP augments antitumor action of the CP/TNFalpha combination in vivo.
Petrova EE; Simonova MA; Komaleva RL; Britsina MV; Andronova TM; Nesmeyanov VA; Valyakina TI
Biomed Pharmacother; 2010 Apr; 64(4):240-8. PubMed ID: 19932583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]